Correction: Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer

Yuejie Zhu; Xiang Li; Qi Zhang; Xiantao Yang; Xudong Sun; Yi Pan; Xia Yuan; Yuan Ma; Bo Xu; Zhenjun Yang

doi:10.1039/D4MD90013H

Correction: Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer

Yuejie Zhu,^a Xiang Li,^a Qi Zhang,^a Xiantao Yang,^ab Xudong Sun,^a Yi Pan,^a Xia Yuan,^a Yuan Ma,^a Bo Xu^a and Zhenjun Yang*^a

Author affiliations

* Corresponding authors

^a State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China
E-mail: yangzj@bjmu.edu.cn
Fax: +86 10 82802503
Tel: +86 10 82802503

^b School of Pharmacy, Chengdu Medical College, 783 Xindu Avenue, Xindu District, Chengdu, China

Abstract

Correction for ‘Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer’ by Yuejie Zhu et al., RSC Med. Chem., 2024, https://doi.org/10.1039/d3md00752a.

RSC Medicinal Chemistry

Correction: Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer

Social activity

Search articles by author

Spotlight

Advertisements